Author: Scott Welch
Ibuprofen can be a blessing for those with aches and pains, but overdoing it poses serious risks.
Offering group health coverage is important to small businesses. More than 9 in 10 said it’s important, with 69% calling it “extremely important.”
9 in 10 employers are concerned about high-cost drugs in the pipeline, with a similar number reporting concern about pharmacy cost trends overall.
A recent hearing at the U.S. House of Representative Health Subcommittee of the Energy and Commerce Committee heard testimony from shareholders and policy experts on costs and price transparency.
Seven durable medical equipment companies cost the Medicare system $2 billion in payments, the National Association of ACOs (NAACOS) told the federal government in recent months. But it's unclear just how problematic that will be for accountable care organizations.
Americans are catching up on healthcare missed during the COVID-19 pandemic, a trend driven by heart procedures and outpatient orthopedic surgeries that likely won’t soon slow, according to interviews with three hospital officials in major U.S. cities, but other factors may also be at play. U.S. health insurers have warned of high demand for medical ...
Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with in 2010. The drugs have kept his cancer at bay. But their rapidly increasing costs so infuriated Mitchell that he was inspired to create an ...
Millions of Medi-Cal beneficiaries can now save for a rainy day, keep an inheritance, or hold on to a modest nest egg, without losing coverage, thanks to an eligibility change phased in over the past year and a half. It also has opened the door for thousands who previously did not qualify for Medi-Cal, the health insurance ...
The Consolidated Appropriations Act (CAA) of 2021 introduced a web of transparency-related regulations and compliance items for health plans, insurance issuers, agents, and providers – all intending to improve clarity and accountability in health care. The CAA prioritizes transparency in health care by requiring annual reports from plans and insurance issuers on prescription drug costs and overall ...
The Consolidated Appropriations Act (CAA) of 2021 created a myriad of new compliance requirements for health plans and insurance issuers, aiming to increase “transparency” in health care. One key requirement is the Rx Data Collection (RxDC), which requires plans and issuers to report on prescription drug and health care spending for the 2023 calendar year by ...